Work

EVOLENCE
Industry: Medical Devices
EVOLENCE injectable filler, developed by ColBar LifeScience Ltd., utilizes the GLYMATRIX technology to create a professionally administered, injectable treatment for soft tissue deficiencies, especially facial wrinkles. In 2006 EVOLENCE was purchased by Johnson & Johnson, and gained FDA approval in 2007.
Despite the fierce competition in the aesthetic medicine field, EVOLENCE has managed to establish a significant position among its adversaries, and has become a necessary part of the aesthetic clinic portfolio.
Project included:
-
Global marketing plan
-
Naming and brand positioning
-
Visual identity
-
Marketing collateral
-
Online presence
-
Training and education
-
Advisory board management
-
Exhibitions and industry events
-
PR activities
Project partners:
-
Wolff Olins branding
-
Jason&Jason Visual Communications
-
Ozone Communications
-
Miri Davidovitz photography
-
Gerber Communications
-
Tal Arazi Visual Communications
-
Wells Healthcare
-
AR Print
-
RM Studio
-
YKM web design
-
InterbrandWood NY



